FGFR3/fibroblast Growth Factor Receptor 3 Inhibits Autophagy Through Decreasing the ATG12-ATG5 Conjugate, Leading to the Delay of Cartilage Development in Achondroplasia

Overview

Journal Autophagy

Specialty Cell Biology

Date 2015 Oct 23

PMID 26491898

Citations 26

Authors

Xiaofeng Wang

Huabing Qi

Quan Wang

Ying Zhu

Xianxing Wang

Min Jin

Qiaoyan Tan

Qizhao Huang

Wei Xu

Xiaogang Li

Liang Kuang

Yubing Tang

Xiaolan Du

Di Chen

Lin Chen

Affiliations

Soon will be listed here.

Abstract

FGFR3 (fibroblast growth factor receptor 3) is a negative regulator of endochondral ossification. Gain-of-function mutations in FGFR3 are responsible for achondroplasia, the most common genetic form of dwarfism in humans. Autophagy, an evolutionarily conserved catabolic process, maintains chondrocyte viability in the growth plate under stress conditions, such as hypoxia and nutritional deficiencies. However, the role of autophagy and its underlying molecular mechanisms in achondroplasia remain elusive. In this study, we found activated FGFR3 signaling inhibited autophagic activity in chondrocytes, both in vivo and in vitro. By employing an embryonic bone culture system, we demonstrated that treatment with autophagy inhibitor 3-MA or chloroquine led to cartilage growth retardation, which mimics the effect of activated-FGFR3 signaling on chondrogenesis. Furthermore, we found that FGFR3 interacted with ATG12-ATG5 conjugate by binding to ATG5. More intriguingly, FGFR3 signaling was found to decrease the protein level of ATG12-ATG5 conjugate. Consistently, using in vitro chondrogenic differentiation assay system, we showed that the ATG12-ATG5 conjugate was essential for the viability and differentiation of chondrocytes. Transient transfection of ATG5 partially rescued FGFR3-mediated inhibition on chondrocyte viability and differentiation. Our findings reveal that FGFR3 inhibits the autophagic activity by decreasing the ATG12-ATG5 conjugate level, which may play an essential role in the pathogenesis of achondroplasia.

Citing Articles

Fibroblast growth factor receptor 3 mutation promotes HSPB6-mediated cuproptosis in hypochondroplasia by impairing chondrocyte autophagy.

Chen J, He D, Yuan C, Li N, Shi B, Niu C J Orthop Translat. 2025; 51:68-81.

PMID: 39991457 PMC: 11847030. DOI: 10.1016/j.jot.2025.01.011.

FGFR antagonists restore defective mandibular bone repair in a mouse model of osteochondrodysplasia.

Morice A, de La Seigliere A, Kany A, Khonsari R, Bensidhoum M, Puig-Lombardi M Bone Res. 2025; 13(1):12.

PMID: 39837840 PMC: 11751307. DOI: 10.1038/s41413-024-00385-x.

FGFR3 alterations in bladder cancer: Sensitivity and resistance to targeted therapies.

Noeraparast M, Krajina K, Pichler R, Niedersuss-Beke D, Shariat S, Grunwald V Cancer Commun (Lond). 2024; 44(10):1189-1208.

PMID: 39161208 PMC: 11483561. DOI: 10.1002/cac2.12602.

FGFR2-triggered autophagy and activation of Nrf-2 reduce breast cancer cell response to anti-ER drugs.

Gorska-Arcisz M, Popeda M, Braun M, Piasecka D, Nowak J, Kitowska K Cell Mol Biol Lett. 2024; 29(1):71.

PMID: 38745155 PMC: 11092031. DOI: 10.1186/s11658-024-00586-6.

Il-1β Promotes Superficial Zone Cells Senescence in Articular Cartilage by Inhibiting Autophagy.

Xu W, Wang J, Cui L, Huang C, Xia N, Xie M Cartilage. 2023; 15(4):428-439.

PMID: 37650417 PMC: 11523166. DOI: 10.1177/19476035231194771.

References

Yamanaka Y, Tanaka H, Koike M, Nishimura R, Seino Y . PTHrP rescues ATDC5 cells from apoptosis induced by FGF receptor 3 mutation. J Bone Miner Res. 2003; 18(8):1395-403. DOI: 10.1359/jbmr.2003.18.8.1395. View

Krejci P, Salazar L, Kashiwada T, Chlebova K, Salasova A, Thompson L . Analysis of STAT1 activation by six FGFR3 mutants associated with skeletal dysplasia undermines dominant role of STAT1 in FGFR3 signaling in cartilage. PLoS One. 2008; 3(12):e3961. PMC: 2597732. DOI: 10.1371/journal.pone.0003961. View

Bohensky J, Leshinsky S, Srinivas V, Shapiro I . Chondrocyte autophagy is stimulated by HIF-1 dependent AMPK activation and mTOR suppression. Pediatr Nephrol. 2009; 25(4):633-42. PMC: 2828515. DOI: 10.1007/s00467-009-1310-y. View

Strober W . Monitoring cell growth. Curr Protoc Immunol. 2008; Appendix 3:Appendix 3A. DOI: 10.1002/0471142735.ima03as21. View

Jin M, Klionsky D . Regulation of autophagy: modulation of the size and number of autophagosomes. FEBS Lett. 2014; 588(15):2457-63. PMC: 4118767. DOI: 10.1016/j.febslet.2014.06.015. View

Chen L, Adar R, Yang X, Monsonego E, Li C, Hauschka P . Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. J Clin Invest. 1999; 104(11):1517-25. PMC: 409856. DOI: 10.1172/JCI6690. View

Naski M, Colvin J, Coffin J, Ornitz D . Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. Development. 1998; 125(24):4977-88. DOI: 10.1242/dev.125.24.4977. View

Bohensky J, Terkhorn S, Freeman T, Adams C, Garcia J, Shapiro I . Regulation of autophagy in human and murine cartilage: hypoxia-inducible factor 2 suppresses chondrocyte autophagy. Arthritis Rheum. 2009; 60(5):1406-15. PMC: 2747039. DOI: 10.1002/art.24444. View

Cecconi F, Levine B . The role of autophagy in mammalian development: cell makeover rather than cell death. Dev Cell. 2008; 15(3):344-357. PMC: 2688784. DOI: 10.1016/j.devcel.2008.08.012. View

10.

Hanada T, Noda N, Satomi Y, Ichimura Y, Fujioka Y, Takao T . The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy. J Biol Chem. 2007; 282(52):37298-302. DOI: 10.1074/jbc.C700195200. View

11.

Hall-Glenn F, Aivazi A, Akopyan L, Ong J, Baxter R, Benya P . CCN2/CTGF is required for matrix organization and to protect growth plate chondrocytes from cellular stress. J Cell Commun Signal. 2013; 7(3):219-30. PMC: 3709047. DOI: 10.1007/s12079-013-0201-y. View

12.

Bohensky J, Shapiro I, Leshinsky S, Watanabe H, Srinivas V . PIM-2 is an independent regulator of chondrocyte survival and autophagy in the epiphyseal growth plate. J Cell Physiol. 2007; 213(1):246-51. DOI: 10.1002/jcp.21117. View

13.

Yang J, Carra S, Zhu W, Kampinga H . The regulation of the autophagic network and its implications for human disease. Int J Biol Sci. 2013; 9(10):1121-33. PMC: 3858585. DOI: 10.7150/ijbs.6666. View

14.

Vajo Z, Francomano C, Wilkin D . The molecular and genetic basis of fibroblast growth factor receptor 3 disorders: the achondroplasia family of skeletal dysplasias, Muenke craniosynostosis, and Crouzon syndrome with acanthosis nigricans. Endocr Rev. 2000; 21(1):23-39. DOI: 10.1210/edrv.21.1.0387. View

15.

Pyo J, Jang M, Kwon Y, Lee H, Jun J, Woo H . Essential roles of Atg5 and FADD in autophagic cell death: dissection of autophagic cell death into vacuole formation and cell death. J Biol Chem. 2005; 280(21):20722-9. DOI: 10.1074/jbc.M413934200. View

16.

Du X, Xie Y, Xian C, Chen L . Role of FGFs/FGFRs in skeletal development and bone regeneration. J Cell Physiol. 2012; 227(12):3731-43. DOI: 10.1002/jcp.24083. View

17.

Bell B, Leverrier S, Weist B, Newton R, Arechiga A, Luhrs K . FADD and caspase-8 control the outcome of autophagic signaling in proliferating T cells. Proc Natl Acad Sci U S A. 2008; 105(43):16677-82. PMC: 2575479. DOI: 10.1073/pnas.0808597105. View

18.

Ewing R, Chu P, Elisma F, Li H, Taylor P, Climie S . Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol Syst Biol. 2007; 3:89. PMC: 1847948. DOI: 10.1038/msb4100134. View

19.

Yasoda A, Kitamura H, Fujii T, Kondo E, Murao N, Miura M . Systemic administration of C-type natriuretic peptide as a novel therapeutic strategy for skeletal dysplasias. Endocrinology. 2009; 150(7):3138-44. PMC: 2703521. DOI: 10.1210/en.2008-1676. View

20.

Zhang J, Liu J, Huang Y, Chang J, Liu L, McKeehan W . FRS2α-mediated FGF signals suppress premature differentiation of cardiac stem cells through regulating autophagy activity. Circ Res. 2011; 110(4):e29-39. PMC: 3677753. DOI: 10.1161/CIRCRESAHA.111.255950. View